Goldman Sachs’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-2,290
| Closed | -$21K | – | 6931 |
|
|
2022
Q1 | $21K | Sell |
2,290
-402
| -15% | -$6.11K | ﹤0.01% | 6409 |
|
|
2021
Q4 | $58K | Sell |
2,692
-9,167
| -77% | -$245K | ﹤0.01% | 6239 |
|
|
2021
Q3 | $388K | Sell |
11,859
-13,674
| -54% | -$501K | ﹤0.01% | 5349 |
|
|
2021
Q2 | $1.06M | Buy |
25,533
+17,786
| +230% | +$911K | ﹤0.01% | 4709 |
|
|
2021
Q1 | $507K | Buy |
7,747
+798
| +11% | +$55.7K | ﹤0.01% | 5110 |
|
|
2020
Q4 | $456K | Sell |
6,949
-1,252
| -15% | -$81.6K | ﹤0.01% | 4661 |
|
|
2020
Q3 | $445K | Buy |
8,201
+710
| +9% | +$54.3K | ﹤0.01% | 4543 |
|
|
2020
Q2 | $715K | Buy |
7,491
+5,473
| +271% | +$408K | ﹤0.01% | 4171 |
|
|
2020
Q1 | $103K | Sell |
2,018
-5,659
| -74% | -$591K | ﹤0.01% | 4937 |
|
|
2019
Q4 | $631K | Buy |
7,677
+3,287
| +75% | +$230K | ﹤0.01% | 4370 |
|
|
2019
Q3 | $376K | Buy |
4,390
+493
| +13% | +$52.6K | ﹤0.01% | 4577 |
|
|
2019
Q2 | $497K | Buy |
3,897
+308
| +9% | +$44.4K | ﹤0.01% | 4403 |
|
|
2019
Q1 | $647K | Buy |
3,589
+1,002
| +39% | +$145K | ﹤0.01% | 4286 |
|
|
2018
Q4 | $287K | Buy |
2,587
+1,920
| +288% | +$250K | ﹤0.01% | 4656 |
|
|
2018
Q3 | $90K | Buy |
+667
| New | +$92K | ﹤0.01% | 5172 |
|
|
2018
Q2 | – | Sell |
-1,260
| Closed | -$174K | – | 6141 |
|
|
2018
Q1 | $174K | Buy |
1,260
+7
| +0.6% | +$953 | ﹤0.01% | 5063 |
|
|
2017
Q4 | $154K | Buy |
+1,253
| New | +$172K | ﹤0.01% | 5553 |
|
|
2017
Q3 | – | Sell |
-2,926
| Closed | -$513K | – | 6951 |
|
|
2017
Q2 | $513K | Buy |
2,926
+60
| +2% | +$8.53K | ﹤0.01% | 5075 |
|
|
2017
Q1 | $344K | Buy |
2,866
+984
| +52% | +$102K | ﹤0.01% | 5349 |
|
|
2016
Q4 | $183K | Buy |
1,882
+623
| +49% | +$57.1K | ﹤0.01% | 5828 |
|
|
2016
Q3 | $118K | Sell |
1,259
-93
| -7% | -$9.32K | ﹤0.01% | 6146 |
|
|
2016
Q2 | $146K | Sell |
1,352
-586
| -30% | -$68.6K | ﹤0.01% | 5910 |
|
|
2016
Q1 | $233K | Buy |
1,938
+767
| +65% | +$80.5K | ﹤0.01% | 5484 |
|
|
2015
Q4 | $139K | Sell |
1,171
-346
| -23% | -$44.6K | ﹤0.01% | 5977 |
|
|
2015
Q3 | $259K | Buy |
1,517
+42
| +3% | +$8.05K | ﹤0.01% | 5746 |
|
|
2015
Q2 | $286K | Buy |
1,475
+165
| +13% | +$30.6K | ﹤0.01% | 5788 |
|
|
2015
Q1 | $194K | Sell |
1,310
-616
| -32% | -$93.8K | ﹤0.01% | 6037 |
|
|
2014
Q4 | $300K | Sell |
1,926
-2,730
| -59% | -$393K | ﹤0.01% | 5778 |
|
|
2014
Q3 | $668K | Sell |
4,656
-769
| -14% | -$111K | ﹤0.01% | 5016 |
|
|
2014
Q2 | $708K | Buy |
5,425
+289
| +6% | +$36.7K | ﹤0.01% | 5027 |
|
|
2014
Q1 | $629K | Sell |
5,136
-329
| -6% | -$35.6K | ﹤0.01% | 5068 |
|
|
2013
Q4 | $580K | Sell |
5,465
-3,917
| -42% | -$380K | ﹤0.01% | 5183 |
|
|
2013
Q3 | $1.05M | Buy |
9,382
+4,363
| +87% | +$495K | ﹤0.01% | 4547 |
|
|
2013
Q2 | $567K | Buy |
+5,019
| New | +$614K | ﹤0.01% | 4831 |
|
Other funds holding SRGA
AWS
CLG
Goldman Sachs's SRGA Position: Q2 2022 in Review
Goldman Sachs sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q2 2022, closing a stake of 2,290 shares — an estimated $21K sold.
Goldman Sachs first reported a position in SRGA in Q2 2013 and held it in 34 quarters. The position peaked at $1.06M in Q2 2021. 40 funds tracked by Wall St. Rank hold SRGA as of Q2 2022.
- Goldman Sachs reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
- Goldman Sachs sold 2,290 Surgalign Holdings, Inc. Common Stock shares in Q2 2022, an estimated $21K.
- Goldman Sachs first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2013 and held it in 34 quarters.
- Goldman Sachs's Surgalign Holdings, Inc. Common Stock position peaked at $1.06M in Q2 2021.
- 40 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q2 2022.
Based on Goldman Sachs's 13F filing for Q2 2022, filed 15 Aug 2022.